A novel platelet-rich plasma clinically induces reliable, rapid, long-term chronic peripheral neuropathic pain elimination
Experimental Biology and Medicine · 2026
DOI: 10.3389/ebm.2026.10907 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Biology and Medicine, 2026. Verfasst von Damien P Kuffler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neurobiology, Medical School, University of Puerto Rico, San Juan, PR, United States. Hauptthemen laut MEDLINE: Platelet-Rich Plasma, Neuralgia, Peripheral Nerve Injuries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Peripheral nerve trauma results in 50%–84% of patients developing chronic neuropathic pain, which is eliminated when axons reinnervate targets. Autografts reduce pain by promoting target reinnervation. We hypothesized that applying a novel platelet-rich plasma (PRP) formulation to proximal stumps would permanently eliminate the pain. This prospective case series compared analgesia levels after bridging nerve gaps with an autograft (autograft repair) vs. a PRP-filled collagen tube (PRP repair). Autograft repairs were performed on 16 nerves with a 5.75-cm mean gap length, 2.0-year repair delay, 42.3-year age, and 8.6 chronic neuropathic pain. PRP repairs were performed on 10 nerves with a 6.0-cm gap length, 1-year repair delay, 36.7-year age, with 88% having 9.1 chronic neuropathic pain. For autograft repairs, the pain began to decrease when axons reinnervated targets, reaching a mean of 0.3 in 18.2% of patients, and was eliminated in 81.8%. Following PRP repairs, the pain reduction began within 2 weeks and was eliminated by 2 months. Thus, autografts contribute to pain reduction/elimination by promoting target reinnervation. However, PRP directly and rapidly induced long-term pain elimination in all patients, while axons were regenerating, and without target reinnervation. These results prove that platelet-released factors reliably and rapidly eliminate chronic neuropathic pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Neurobiology, Medical School, University of Puerto Rico, San Juan, PR, United States.
- Doctor's Center Hospital, Manati, PR, United States.
- Section of Neurosurgery, Medical School, University of Puerto Rico, San Juan, PR, United States.
- Section of Orthopedic Surgery, Medical Sciences Campus, University of Puerto Rico, San Juan, PR, United States.
Zitieren
APA
Kuffler, D. P., Reyes, O., Sosa, I. J., & Foy, C. A. (2026). A novel platelet-rich plasma clinically induces reliable, rapid, long-term chronic peripheral neuropathic pain elimination. Experimental Biology and Medicine. https://doi.org/10.3389/ebm.2026.10907
Vancouver
Kuffler DP, Reyes O, Sosa IJ, Foy CA. A novel platelet-rich plasma clinically induces reliable, rapid, long-term chronic peripheral neuropathic pain elimination. Experimental Biology and Medicine. 2026. doi:10.3389/ebm.2026.10907
BibTeX
@article{Kuffler2026,
author = {Kuffler, Damien P and Reyes, Onix and Sosa, Ivan J and Foy, Christian A},
title = {A novel platelet-rich plasma clinically induces reliable, rapid, long-term chronic peripheral neuropathic pain elimination},
journal = {Experimental Biology and Medicine},
year = {2026},
doi = {10.3389/ebm.2026.10907}
}
EUVIMED